logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
G

Guru Sonpavde

AdventHealth Cancer Institute
H指数:77
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bispecific dual T cell agonist invikafusp alfa in solid tumors: the phase 1/2 START-001 trial

双特异性双T细胞激动剂invikafusp alfa在实体瘤中的研究：第1/2期START-001试验

Nature Medicine
IF50
2026-10-230
PRE
Ryan J. Sullivan; Nicholas P. Tschernia; Claire F. Friedman; Mercedes Herrera; Guru P. Sonpavde; Kai He; Antoine Italiano; Aurélien Marabelle; Matthieu Roulleaux-Dugage; François-Xavier Danlos; Elena Garralda Cabanas; Alberto Hernando-Calvo; Manuel Pedregal; Aparna Parikh; Gopakumar Iyer; Ahmed Zakari; E. John Wherry; Jeffrey Schlom; Renee N. Donahue; Shannon McCue; Sharon Cross; Karunya Srinivasan; Lisa Benincosa; Madan Katragadda; Zhenming Shun; Kevin Chin; Zhen Su; Ke Liu; Lillian L. Siu; James L. Gulley
Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial

Linavonkibart和pembrolizumab在免疫检查点阻断耐药的晚期实体瘤中的应用: 1期试验

Nature Medicine
IF50
2026-01-130
OAAI
Timothy A. Yap; Randy F. Sweis; Ulka Vaishampayan; Deepak Kilari; Justin F. Gainor; Meredith McKean; Minal Barve; Ahmad A. Tarhini; Bruno Bockorny; Guru Sonpavde; David Park; Sunil Babu; Yawen Ju; Lan Liu; Susan Henry; Giridhar S. Tirucherai; Stephen DeWall; Mohammed Qatanani; Jing L. Marantz; Lu Gan
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

高级泌尿肿瘤共识会议（AUC3）2025：肾细胞癌和尿路肿瘤管理的专家共识

CA: A Cancer Journal for Clinicians
IF0
2025-12-130
OAAI
Rana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
A sensitive and specific non-invasive urine biomarker panel for prostate cancer detection

一种用于前列腺癌检测的敏感且特异的无创尿液生物标志物组合

eBioMedicine
IF10.8
2025-09-020
OAAI
Menglang Yuan; Marcio Covas Moschovas; Kandarp Joshi; Yohei Sanada; Roshane A. Perera; Bongyong Lee; Rudramani Pokhrel; Jiri Polivka; Alexandra Miller; Ernest K. Amankwah; Ignacio Gonzalez-Gomez; Naren Nimmagadda; Ezra Baraban; Anant Jaiswal; Cuncong Zhong; Inoel Rivera; Guru P. Sonpavde; Chetan Bettegowda; Vipul Patel; Christian P. Pavlovich; Ranjan J. Perera
Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial

CheckMate 901试验中，仅淋巴结转移性尿路上皮癌患者接受纳武利尤单抗联合吉西他滨-顺铂治疗与单独吉西他滨-顺铂治疗的特征分析

European Urology
IF25.2
2025-05-200
OAAI
Matthew D. Galsky; Michiel S. van der Heijden; Thomas Powles; Melanie Claps; Mauricio Burotto; Michael Schenker; Juan Pablo Sade; Aristotelis Bamias; Philippe Beuzeboc; Jens Bedke; Jan Oldenburg; Yüksel Ürün; Dingwei Ye; Begoña P. Valderrama; Yoshihiko Tomita; Ruiyun Jiang; Jeiry Filian; Lily Wang; Maximiliano van Kooten Losio; Guru Sonpavde
A pilot study of [18F]F-fluciclovine positron emission tomography/computed tomography for staging muscle invasive bladder cancer preceding radical cystectomy

一项关于[18F]F-fluciclovine正电子发射断层扫描/计算机断层扫描在根治性膀胱切除术前的肌层浸润性膀胱癌分期作用的初步研究

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
IF7.6
2025-04-210
PRE
Ng, Thomas S. C.; Liu, Mofei; Robertson, Matthew; Konik, Arda; Cheng, Su Chun; Bakht, Martin K.; Harrington, Kristen; Wolanski, Andrew; Gilbert, Lauren; Preston, Mark; Mossanen, Matthew; Beltran, Himisha; Hirsch, Michelle S.; Sonpavde, Guru; Jacene, Heather A.
Alliance A031501: AMBASSADOR study of adjuvant pembrolizumab (Pembro) in muscle-invasive urothelial carcinoma (MIUC) vs observation (Obs): Extended follow-up disease-free survival (DFS) results and metastatic (met) disease recurrence distribution

联盟A031501：AMBASSADOR研究，评估辅助治疗中帕博利珠单抗（Pembro）在肌肉浸润性尿路上皮癌（MIUC）与观察（Obs）相比的扩展随访无病生存期（DFS）结果及转移性（met）疾病复发的分布

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Apolo, A. B.; Ballman, K.; Sonpavde, G. P.; Berg, S.; Kim, W.; Parikh, R.; Teo, M. Y.; Sweis, R. F.; Geynisman, D.; Grivas, P.; Chatta, G.; Reichert, Z.; Kim, J. W.; Bilen, M. A.; McGregor, B. A.; Srinivas, S.; Halabi, S.; Burbano, G. Perez; Morris, M. J.; Rosenberg, J. E.
Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy

EV-301既往接受过治疗的晚期尿路上皮癌患者的健康相关生活质量: Enfortumab Vedotin与化疗的3期试验

EUROPEAN UROLOGY
IF25.2
2024-06-014
OAAI
Rosenberg, Jonathan E.; Mamtani, Ronac; Sonpavde, Guru P.; Loriot, Yohann; Duran, Ignacio; Lee, Jae-Lyun; Matsubara, Nobuaki; Vulsteke, Christof; Castellano, Daniel; Sridhar, Srikala S.; Pappot, Helle; Gurney, Howard; Bedke, Jens; van der Heijden, Michiel S.; Galli, Luca; Keam, Bhumsuk; Masumori, Naoya; Meran, Johannes; O'Donnell, Peter H.; Park, Se Hoon; Grande, Enrique; Sengelov, Lisa; Uemura, Hiroji; Skaltsa, Konstantina; Campbell, Mary; Matsangou, Maria; Wu, Chunzhang; Hepp, Zsolt; Mckay, Caroline; Powles, Thomas; Petrylak, Daniel P.

研究方向

暂未获取到该数据
T
Toni K. Choueiri
H 指数:149论文数:2,478被引数:12.6万
M
Matthew D. Galsky
H 指数:79论文数:852被引数:3.4万
J
Joaquim Bellmunt
H 指数:106论文数:1,140被引数:6.6万
A
Andrea Necchi
H 指数:70论文数:1,307被引数:3.2万
G
Gregory R. Pond
H 指数:79论文数:972被引数:2.3万
N
Noah M. Hahn
H 指数:58论文数:576被引数:1.8万
G
Giuseppe Di Lorenzo
H 指数:60论文数:523被引数:1.1万
S
Sumanta K. Pal
H 指数:88论文数:1,402被引数:3.4万
S
Seth P. Lerner
H 指数:86论文数:722被引数:3.5万
P
Petros Grivas
H 指数:61论文数:916被引数:2.4万